Hostname: page-component-586b7cd67f-vdxz6 Total loading time: 0 Render date: 2024-11-25T06:37:42.930Z Has data issue: false hasContentIssue false
  • English
  • Français

Emergence of Carbapenem Resistance in Acinetobacter baumannii Recovered From Blood Cultures in Australia

Published online by Cambridge University Press:  08 April 2017

Anton Y. Peleg ,
Clare Franklin ,
Jan M. Bell  and
Denis W. Spelman
Anton Y. Peleg*
Affiliation:
Alfred Hospital, Melbourne, Australia Division of Infectious Diseases, Beth Israel Deaconess Medical Center, and, Harvard Medical School, Boston, Massachusetts
Clare Franklin
Affiliation:
Alfred Hospital, Melbourne, Australia
Jan M. Bell
Affiliation:
Women's and Children's Hospital, Adelaide, Australia
Denis W. Spelman
Affiliation:
Alfred Hospital, Melbourne, Australia
*
Infectious Diseases Unit, Alfred Hospital, Commercial Road, Prahran, 3181, Melbourne, Victoria, Australia ([email protected])
Get access Rights & Permissions [Opens in a new window]

Abstract

We describe the first emergence of carbapenem-resistant Acinetobacter baumannii in Australia. Ninety A. baumannii isolates recovered from cultures of blood specimens from 69 patients were analyzed. Overall, 58 isolates (64%) were resistant to meropenem. The χ2 test for linear trend revealed that emergence of carbapenem resistance was statistically significant during the 32-month study period. Selected isolates were of the same clonal type, and no genes encoding carbapenemases were identified.

Type
Concise Communications
Information
Infection Control & Hospital Epidemiology , Volume 27 , Issue 7 , July 2006 , pp. 759 - 761
Copyright
Copyright © The Society for Healthcare Epidemiology of America 2006

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

1.Villegas, MV, Hartstein, AI. Acinetobacter outbreaks, 1977-2000. Infect Control Hosp Epidemiol 2003;24:284–295.CrossRefGoogle ScholarPubMed
2.Bergogne-Berezin, E, Towner, KJ. Acinetobacter spp. as nosocomial pathogens: microbiological, clinical, and epidemiological features. Clin Microbiol Rev 1996;9:148–165.CrossRefGoogle ScholarPubMed
3.Nordmann, P, Poirel, L. Emerging carbapenemases in gram-negative aerobes. Clin Microbiol Infect 2002; 8:321–331.CrossRefGoogle ScholarPubMed
4.Quale, J, Bratu, S, Landman, D, Heddurshetti, R. Molecular epidemiology and mechanisms of carbapenem resistance in Acinetobacter baumannii endemic in New York City. Clin Infect Dis 2003; 37:214–220.CrossRefGoogle ScholarPubMed
5.Dalla-Costa, LM, Coelho, JM, Souza, HA, et al. Outbreak of carbapenem-resistant Acinetobacter baumannii producing the OXA-23 enzyme in Curitiba, Brazil. J Clin Microbiol 2003; 41:3403–3406.CrossRefGoogle ScholarPubMed
6.Corbella, X, Montero, A, Pujol, M, et al. Emergence and rapid spread of carbapenem resistance during a large and sustained hospital outbreak of multiresistant Acinetobacter baumannii. J Clin Microbiol 2000; 38:4086–4095.CrossRefGoogle ScholarPubMed
7.Jeon, BC, Jeong, SH, Bae, IK, et al. Investigation of a nosocomial outbreak of imipenem-resistant Acinetobacter baumannii producing the OXA-23 beta-lactamase in Korea. J Clin Microbiol 2005; 43:2241–2245.CrossRefGoogle ScholarPubMed
8.Tenover, FC, Arbeit, RD, Goering, RV, et al. Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing. J Clin Microbiol 1995; 33:2233–2239.CrossRefGoogle ScholarPubMed
9.Yan, JJ, Hsueh, PR, Ko, WC, et al. Metallo-beta-lactamases in clinical Pseudomonas isolates in Taiwan and identification of VIM-3, a novel variant of the VIM-2 enzyme. Antimicrob Agents Chemother 2001; 45:2224–2228.CrossRefGoogle ScholarPubMed
10.Senda, K, Arakawa, Y, Ichiyama, S, et al. PCR detection of metallo-beta-lactamase gene (blaIMP) in gram-negative rods resistant to broad-spectrum beta-lactams. J Clin Microbiol 1996; 34:2909–2913.CrossRefGoogle ScholarPubMed
11.Afzal-shah, M, Woodford, N, Livermore, DM. Characterization of OXA-25, OXA-26, and OXA-27, molecular class D beta-lactamases associated with carbapenem resistance in clinical isolates of Acinetobacter baumannii. Antimicrob Agents Chemother 2001; 45:583–588.CrossRefGoogle Scholar
12.Poirel, L, Marque, S, Heritier, C, Segonds, C, Chabanon, G, Nordmann, P. OXA-58, a novel class D β-lactamase involved in resistance to carbapenems in Acinetobacter baumannii. Antimicrob Agents Chemother 2005; 49:202–208.CrossRefGoogle Scholar
13.Hughes, VM, Datta, N. Conjugative plasmids in bacteria of the ‘pre-antibiotic’ era. Nature 1983; 302:725–726.CrossRefGoogle ScholarPubMed
14.Ferreira, AC, Gobara, S, Costa, SE, et al. Emergence of resistance in Pseudomonas aeruginosa and Acinetobacter species after the use of antimicrobials for burned patients. Infect Control Hosp Epidemiol 2004; 25:868–872.CrossRefGoogle ScholarPubMed
15.Ibrahim, EH, Sherman, G, Ward, S, Fraser, VJ, Kollef, MH. The influence of inadequate antimicrobial treatment of bloodstream infections on patient outcomes in the ICU setting. Chest 2000; 118:146–155.CrossRefGoogle ScholarPubMed